Tower Research Capital LLC (Trc) Insmed Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Insmed Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,293 shares of INSM stock, worth $178,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,293
Previous 23,509
90.25%
Holding current value
$178,005
Previous $1.58 Million
89.4%
% of portfolio
0.0%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding INSM
# of Institutions
478Shares Held
180MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.33 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.11 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$977 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$815 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$506 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.5B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...